Over the course of the last several years the government has mandated that medical records be kept for seven years and be kept in an electronic format.
This has led to a proliferation of proprietary formats which has made the integration of medical records difficult if not impossible. It has also made the use by a patient essentially impractical. The management believes that there exists a need for accurate patient friendly access to medical information that is not dependent on patient input or compliance.
As we have an aging population it has become increasingly important for these patients to have accurate information on the exact type and dose of their medications. This information is available from the pharmacies that a patient uses. Management is in the early phase of developing a business plan incorporating the pharmacy output to the label printer to be copied to a secure database specifically accessed by either the patient or a qualified first responder. This would permit the first responder to be able to immediately access the information even if the patient were not fully coherent. While the marketplace has developed several companies with similar objectives they appear at first glance to be dependent on the patient entering the data and they often require the patient to pay for the service.
The Andre Meyer Group over the past several years has been developing proprietary financial software to assist institutions involved in exchange based transactions to develop a platform that is both more intuitive and display additional information in a manner that permits the user to develop strategies to take advantage of the increasingly volatile and fast moving markets. Recently a part of the platform was incorporated into a company called Money. Net with a very positive reaction by the clients. The platform was supplemented by an overlay that was able to point out different entities in a sector that were both more active and whose performance was either increasing or decreasing in value. This information was presented in a graphic user interphase which would permit the user to develop a strategy to take advantage as the situations evolved. An additional module of the financial platform after having been developed to assist in the projection of actionable positions to be taken in the securities environment is being modified to be of use in the commodities environment, particularly in the oil, gas and energy marketplaces.
The development of these type of tools is what the management of the Andre Meyer Group believes is needed to assist the financial markets to reinvent themselves in the current environment of high speed trading. The use of these type of tools assists the professional in the management of a portfolio and is what is needed to re-instill the confidence of the public in the street. This type of approach permits the financial services professional to combine the output of the annalist with the most advanced metric tools to take advantage of fluctuations in the market place as well as to choose those equities which they believe have the most long term promise. It assists in protecting the downside fluctuations while capitalizing in the small but meaningful increases of the security being traded. In short in either the volatile environment or the stagnant market it responds to the needs of the investor if properly managed by protecting against asset loss while taking advantage of capital appreciation and assuring cash flow.
The future of the underlying tools will be to alter the variables and filters to address different markets in different currencies and different environments. It is the opinion of the management that many of the filters and variables will be useful in developing the application for use in both foreign exchanges as well as in the gold and currency markets. It will become increasingly important to address the foreign currency risk as the dollar, as the sole reserve currency, is replaced by either a basket of currencies or alternative currencies. The risk is further complicated by the variable dates of maturity of contracts therefore making it even more important that the currency risk be addressed at the time that the initial contracts are executed. Recently the management has completed the formation of a joint venture with a leading member of the oil and gas industry and hopes to have a viable trading platform completed in the first half of 2016.
It is also the opinion of management that the energy sector of the market place may become increasingly important and develop characteristics of a currency in and of itself. While we do not see this developing immediately we believe that this may evolve in the future so that the trading of these contracts will require new and expanding metrics of evaluation and management. The tools that are currently under development may become important in the future development and oversight of this marketplace by helping to monitor and fulfill future compliance issues.
The most exciting new developments in nano technology is the revolutionary approaches to the development of new ways to treat cancer. This new technology will also probably be used to develop new antibiotics and new imaging of diseased tissue both in the operating room and in the imaging department.
The development of true Nano Technology has become involved with the development of both biological technology the harnessing of microorganisms to develop complex products more efficiently than can be developed by other means or to produce mechanical solutions that are faster smaller and self-repairing than might be produced otherwise. However, an expanded view of this sector of the marketplace would also be the production of new molecules or compounds whose application to problems in both medicine and science give us the ability to evaluate and treat problems or diseases in a manner and at a cost that was hither to unavailable. One of the areas where we see this evolving perhaps in a non-classical manner is in the development of new imaging materials and processes in medicine. Recently a joint venture between MIT and MSKCC has produced a new class of functionality in complex antibody molecules with multiple attachment sites. This new class of molecule has the ability to have several different antigen like fragments attached to it and therefore can be used to specifically bind to a select type of cell. For example it can have an anti-lung cancer antibody attached to it so that if injected into a patient it will bind primarily to cells that have expressed the abnormal lung antigen. The other “arm” of the molecule can have either an imaging agent or a therapeutic agent so that the patient can receive a treatment that would require substantially less toxic material while substantially increasing the local level of toxic material at the disease sight and leaving healthy tissue virtually unharmed. This type of ligand chemistry is now evolved to the point of being developed into a series of anti-neoplastic drugs but in theory the use of this type of mechanism and the development of this type of carrier molecule has much wider implications than just anti neoplastic applications.
We live in a world of increasingly resistant microbes. Not only are the microbes resistant to the normal approach but the cost of the new tertiary antibiotics have become increasingly expensive with serious side effects and even potentially increased implication in the developing epidemic of inflammatory diseases. The new carrier molecule may in the future be able to be harnessed as an agent in the attaching to offending organism and having the second “arm” attached once again to antibacterial agent. This approach is somewhat similar to the old fashioned “quelling” reactions used to identify and treat pneumococcal infections used in the days before antibiotics. While this specific application has yet to be developed it is clear that conceptionally such use of the technology is not beyond reason.
Another application of this technology is to attach a florescent molecule in the place of an imaging agent. This would permit surgeons to identify diseased tissue intraoperatively and lead to a greater success rate when surgical intervention were to be used as part of a treatment regimen.
Because of the very different applications of this technology it would seem that the most efficient manner to approach this type of development would be to set each of the projects under a different division of a company with different budgets and potentially different funding. This is especially important to consider the structure in this case because the best partner might be different for each of these applications.